Navigation Links
BioMed Realty Trust Reports Third Quarter 2010 Financial Results
Date:11/3/2010

SAN DIEGO, Nov. 3, 2010 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the third quarter ended September 30, 2010.

Third Quarter 2010 Highlights

  • Generated record total revenues for the third quarter of $95.7 million, up 3.0% from $93.0 million in the same period in 2009.
  • Increased rental revenues for the third quarter by 6.6% to a record $73.0 million from $68.5 million in the same period in 2009.
  • Increased same property net operating income for the quarter by 6.1% on a cash basis as compared to the same period in 2009.
  • Executed 14 leasing transactions representing approximately 231,700 square feet:
  • Ten new leases totaling approximately 90,400 square feet.
  • Four leases amended to extend their terms, totaling approximately 141,300 square feet.
  • Current operating portfolio 88.2% leased on a weighted average basis.
  • Same property portfolio 88.2% leased, up 190 basis points as compared to the same period in 2009.
  • Acquired three properties in the University Towne Centre, Torrey Pines and Sorrento Valley life science submarkets of San Diego, California, for a total investment of $93.7 million, including:
  • 4570 Executive Drive, a 100% leased property comprising approximately 125,000 square feet.
  • 10240 Science Center Drive, a 100% leased property comprising approximately 49,000 square feet.
  • 11388 Sorrento Valley Road, a 100% leased property comprising approximately 36,000 square feet.
  • Acquired a development site, including a partially completed life science building of approximately 63,000 square feet and vacant land to support the future construction of an additional 103,000 square feet of laboratory and office space, at 4
    '/>"/>

  • SOURCE BioMed Realty Trust, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related biology technology :

    1. Reportlinker Adds Next Generation U.S. and E.U. Biomaterials/BioMedical Devices: Market Trends & Commercial Implications
    2. BioMed Realty Trust Completes South San Francisco Portfolio Acquisition
    3. BioMed Realty Trust to Report 2010 Third Quarter Results
    4. BioSpace and BioMed Central Create Global Career Community
    5. DSM Biomedical Announces Continued Partnership with Spinelab
    6. BioMed Realty Trust Declares Second Quarter 2010 Common Stock and Preferred Stock Dividends
    7. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 2030
    8. BioMed Realty Trust Promotes Greg Lubushkin to Chief Financial Officer
    9. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California
    10. Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion
    11. BioMed Realty Trust to Webcast Company Presentation at Investor Day 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... Protocol Networks brings independent technology consulting to ... independent consultants, Protocol Networks has recently announced its expansion ... years, his company has attracted several clients in The ... well as others. With the success of these engagements, ...
    (Date:1/22/2015)... January 22, 2015 zFlo Motion , ... to announce an exciting product from a new partner. ... solutions over the past 15 years, with offerings in the ... their 3D IMU system (inertial measurement unit), iSen, is opening ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
    (Date:1/22/2015)... 2015   Cypher Genomics, Inc., the leading ... SQNM ), the leading molecular diagnostics company, ... noninvasive prenatal tests (NIPT). Through this agreement, Sequenom ... to advance analysis of clinically-relevant fetal sub-chromosomal variants ...
    Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 23D Motion Capture Just Got Easy 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
    ... BANGKOK, Thailand, Sept. 8 Don Margolis, Chairman ... http://www.RepairStemCells.org ) based in,Bangkok, Thailand told The Wall ... today that future profits inside the stem cell,research ... the next five years, even for,companies specializing in ...
    ... be Presented at the 7th International ... Symposium on Uveitis in Germany, ... of antibody fragment therapeutics, today announced that the,company has successfully ... candidate, ESBA105, in ophthalmic indications. In,April 2008, ESBATech initiated the ...
    ... achieve undetectable HCV RNA levels, following 4 weeks of treatment with R7128 1500mg BID with ... ... ... PRINCETON, N.J., Sept. 8 Pharmasset, Inc.,(Nasdaq: VRUS ) announces the preliminary results of ...
    Cached Biology Technology:Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript 2ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications 2Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 2Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 3Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 4Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 5Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 6
    (Date:1/22/2015)... January 22, 2015 , ... The European Patent Office to present a video retrospective ... nominations to be featured: Christofer Toumazou and Sophie ... finalists and winners of the Award   Starting on ...
    (Date:12/24/2014)... launch in December 2014, the 1U™ app has ... to remember their usernames and passwords through replacing the antiquated ... assist people who have struggled to remember usernames and passwords, ... focuses on redefining identity, announced today that it is offering ...
    (Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & ... http://photos.prnewswire.com/prnh/20130307/600769 ... introduced the fingerprint reading feature with the iPhone 5S. ...
    Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 31U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2
    ... to suit local light conditions, or made more efficient ... are among the imaginative applications foreseen from ground-breaking new ... new, more fully detailed knowledge of how plants and ... dioxide into biomass may offer clues to addressing both ...
    ... experts expect a sea-level rise of 40-60 centimeters by 2100 ... a team of scientists from the USA and Germany. ... a good chance of limiting future sea-level rise to one ... some coastal cities and low-lying islands," says Stefan Rahmstorf from ...
    ... disease patients eventually leads to disability and a lower ... can progress rapidly or slowly. ... first time, identified a biochemical signal in the blood ... biomarker could help doctors predict early on, just after ...
    Cached Biology News:In plant photosynthesis, scientists see clues for improving solar energy cells 2Expert assessment: Sea-level rise could exceed 1 meter in this century 2UCLA, Emory researchers find a chemical signature for 'fast' form of Parkinson's 2
    WD-repeat protein 4...
    ... Cultured human omental preadipocytes ... but otherwise healthy donors. ... of diabetic cells. Please ... Support media also available. ...
    11-keto Testosterone EIA Antiserum hormones steroids antisera antiserum eias enzyme immunoassays reagents 11-keto-testosterone...
    Chaps Cell Extract Buffer can be used to lyse cells under nondenaturing conditions and is recommendedfor the preparation of cell lysates to be used with our caspase signaling pathway antibodies...
    Biology Products: